Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 146 Records) |
| Query Trace: Neoplasms and CYP1A2[original query] |
|---|
| A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density. Breast cancer research : BCR 2015 17 (1): 110. Rudolph Anja, Fasching Peter A, Behrens Sabine, Eilber Ursula, Bolla Manjeet K, Wang Qin, Thompson Deborah, Czene Kamila, Brand Judith S, Li Jingmei, Scott Christopher, Pankratz V Shane, Brandt Kathleen, Hallberg Emily, Olson Janet E, Lee Adam, Beckmann Matthias W, Ekici Arif B, Haeberle Lothar, Maskarinec Gertraud, Le Marchand Loic, Schumacher Fredrick, Milne Roger L, Knight Julia A, Apicella Carmel, Southey Melissa C, Kapuscinski Miroslav K, Hopper John L, Andrulis Irene L, Giles Graham G, Haiman Christopher A, Khaw Kay-Tee, Luben Robert, Hall Per, Pharoah Paul D P, Couch Fergus J, Easton Douglas F, Dos-Santos-Silva Isabel, Vachon Celine, Chang-Claude Jen |
| Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers. Current drug metabolism 2015 16 (10): 850-63. He Xin, Feng Sh |
| Meta-analysis of correlation between the CYP1A2 -3860 G > A polymorphism and lung cancer risk. Genetics and molecular research : GMR 2016 Jun 15 (2): . Ren J, He B Z, Zhang T S, Lu S P, Yan |
| CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study. Genetics and molecular research : GMR 2016 15 (2): . Song Y L, Wang L, Ren J C, Xu Z |
| Associations of CYP1A2 Polymorphisms with the Risk Haplotypes in Lung Cancer in the Slovak Population. Advances in experimental medicine and biology 2016 Mar . Matakova T, Halasova E, Dzian A, Hruby R, Halasa M, Javorka K, Skerenova |
| Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses. BMC cancer 2016 Feb 16 83. Vukovic Vladimir, Ianuale Carolina, Leoncini Emanuele, Pastorino Roberta, Gualano Maria Rosaria, Amore Rosarita, Boccia Stefan |
| Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype. Human genomics 2016 Nov 10 (1): 39. Jorge-Nebert Lucia F, Zhang Ge, Wilson Keith M, Jiang Zhengwen, Butler Randall, Gluckman Jack L, Pinney Susan M, Nebert Daniel |
| [Association between genetic polymorphisms and variation of imatinib pharmacokinetics in gastrointestinal stromal tumors]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2017 Sep 20 (9): 1031-1034. Qiu Haibo, Zhuang Wei, Wang Xueding, Huang Min, Zhou Zhiw |
| The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China. Oncotarget 2017 Mar . Bai Xianan, Xie Jingjing, Sun Shanshan, Zhang Xianyu, Jiang Yongdong, Pang |
| Clinical Pharmacokinetics of Vemurafenib. Clinical pharmacokinetics 2017 Mar . Zhang Weijiang, Heinzmann Dominik, Grippo Joseph |
| Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer. Oncotarget 2017 Nov 8 (59): 100296-100311. Woo Hye In, Lee Se Kyung, Kim Jiyoung, Kim Seok Won, Yu Jonghan, Bae Soo Youn, Lee Jeong Eon, Nam Seok Jin, Lee Soo-Yo |
| Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan. Environmental health and preventive medicine 2017 Oct 22 (1): 72. Koda Masahide, Iwasaki Motoki, Yamano Yuko, Lu Xi, Katoh Takahi |
| Influence of SLCO1B1 in gastric cancer patients treated with EOF chemotherapy. Oncology letters 2018 Oct 16 (4): 4489-4497. Feng Wanjing, Liu Xin, Zhao Xiaoying, Huang Mingzhu, Guo Weijian, Yin Jiliang, Chen Zhiyu, Zhu Xiaodo |
| Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan. Environmental health and preventive medicine 2018 Jul 23 (1): 30. Koda Masahide, Iwasaki Motoki, Yamano Yuko, Lu Xi, Katoh Takahi |
| Frequencies of poor metabolizer alleles of 12 pharmacogenomic actionable genes in Punjabi Sikhs of Indian Origin. Scientific reports 2018 Oct 8 (1): 15742. Sanghera Dharambir K, Bejar Cynthia, Sapkota Bishwa, Wander Gurpreet S, Ralhan Sar |
| Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk. Movement disorders : official journal of the Movement Disorder Society 2018 Jan . Kim Iris Y, O'Reilly Éilis J, Hughes Katherine C, Gao Xiang, Schwarzschild Michael A, McCullough Marjorie L, Hannan Marian T, Betensky Rebecca A, Ascherio Alber |
| Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters. Biological & pharmaceutical bulletin 2018 41 (1): 47-56. Endo-Tsukude Chihiro, Sasaki Ji-Ichiro, Saeki Sho, Iwamoto Norihiro, Inaba Megumi, Ushijima Sunao, Kishi Hiroto, Fujii Shinji, Semba Hiroshi, Kashiwabara Kosuke, Tsubata Yukari, Hayashi Mitsuhiro, Kai Yuki, Saito Hideyuki, Isobe Takeshi, Kohrogi Hirotsugu, Hamada Akino |
| Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population. BMC medical genetics 2019 Sep 20 (1): 148. Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame |
| Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer. Drug metabolism and disposition: the biological fate of chemicals 2020 6 48 (9): 796-803. Turner P Kellie, Hall Stephen D, Chapman Sonya C, Rehmel Jessica L, Royalty Jane E, Guo Yingying, Kulanthaivel Palaniapp |
| Polymorphisms of Drug-Metabolizing Enzymes and Transporters Contribute to the Individual Variations of Erlotinib Steady State Trough Concentration, Treatment Outcomes, and Adverse Reactions in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Patients. Frontiers in pharmacology 2020 11 664. Liao Dehua, Liu Zhigang, Zhang Yongchang, Liu Ni, Yao Dunwu, Cao Lizhi, Chen Yun, Fu Yilan, Yang Nong, Xiang Daxio |
| Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes. Archives of toxicology 2020 11 95 (1): 311-319. Leggett Carmine S, Doll Mark A, States J Christopher, Hein David |
| The role of heterocyclic aromatic amines in colorectal cancer: the evidence from epidemiologic studies. Genes and environment : the official journal of the Japanese Environmental Mutagen Society 2021 6 43 (1): 20. Le Marchand Lo |
| The ovarian carcinoma risk with the polymorphisms of CYP1B1 come from the positive selection. American journal of translational research 2021 13 (5): 4322-4341. Zhang Liying, Feng Liyuan, Lou Meng, Deng Xihan, Liu Chuanzhong, Li |
| Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort. Molecular biology reports 2021 12 49 (2): 1233-1258. Hemissi Imen, Boussetta Sami, Dallali Hamza, Hellal Faycel, Durand Geoffroy, Voegele Catherine, Ayed Haroun, Zaghbib Selim, Naimi Zeineb, Ayadi Mouna, Chebil Mohamed, Mckay James, Le Calvez-Kelm Florence, Ouerhani Sl |
| Differences in ?-naphthylamine metabolism and toxicity in Chinese hamster ovary cell lines transfected with human CYP1A2 and NAT2*4, NAT2*5B or NAT2*7B N-acetyltransferase 2 haplotypes. Archives of toxicology 2022 Aug . Habil Mariam R, Salazar-González Raúl A, Doll Mark A, Hein David |
| Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer. European urology oncology 2022 Aug . Gregg Justin R, Kim Jeri, Logothetis Christopher, Hanash Sam, Zhang Xiaotao, Manyam Ganiraju, Muir Kenneth, , Giles Graham G, Stanford Janet L, Berndt Sonja I, Kogevinas Manolis, Brenner Hermann, Eeles Rosalind A, , Wei Peng, Daniel Carrie |
| Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers in pharmacology 2022 13 918219. Tan Tingfei, Han Gongwei, Cheng Ziwei, Jiang Jiemei, Zhang Li, Xia Zitong, Wang Xinmeng, Xia Qu |
| Effect of N-acetyltransferase 2 genetic polymorphism on 4,4'-methylenebis(2-chloroaniline)-induced genotoxicity and oxidative stress. Archives of toxicology 2023 5 . Mariam R Habil, Raúl A Salazar-González, Mark A Doll, David W He |
| Effects of dose and human N-acetyltransferase 1 genetic polymorphism in benzidine metabolism and genotoxicity. Archives of toxicology 2023 4 . Mariam R Habil, David W He |
| Polymorphisms in the gene encoding CYP1A2 influence prostate cancer risk and progression. Oncology letters 2023 2 25 (2): 85. Vil?ková Marta, Škere?ová Mária, Dobrota Dušan, Kaplán Peter, Jure?eková Jana, Kliment Ján, Híveš Márk, Dušenka Róbert, Evin Daniel, Knoško Brožová Martina, Kme?ová Sivo?ová Moni |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: